Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: RNA

Scripps’ Disney Lab Breakthrough RNA-Targeting Compounds Dismantle COVID-19’s ‘Clutch’ via Disabling Reproduction Engine

Research rockstar Matthew Disney, PhD, and team from Scripps Florida have created drug-like compounds that based on results thus far in […]

Scripps’ Disney Lab Breakthrough RNA-Targeting Compounds Dismantle COVID-19’s ‘Clutch’ via Disabling Reproduction Engine
5 months ago
Share

Independent Aventiv Research Selected by Pfizer & BioNTech for COVID-19 Vaccine Trial: Volunteers Drive 2 Hours to Contribute

Independently-owned Columbus Ohio-based Aventiv Research was selected by the Pfizer/BioNTech “Project Lightspeed” program to participate in the Phase 2/3 clincial […]

Independent Aventiv Research Selected by Pfizer & BioNTech for COVID-19 Vaccine Trial Volunteers Drive 2 Hours to Contribute
7 months ago
Share

Treated at University of Maryland: Could this be the First Vaccinated Person Against SARS-CoV-2?

A Maryland resident could be the first individual in the world to be vaccinated against SARS-CoV-2, the virus behind COVID-19, […]

Treated at University of Maryland, Could this be the First Vaccinated Person against SARS-CoV-2
8 months ago
Share

Imperial College London Making some Power Moves as they Commence Internally Developed COVID-19 Vaccine & Launch ‘Social Enterprise’

Professor Robin Shattock and team at Imperial College London initiated an important COVID-19 vaccine clinical trial recently as they prepare […]

Imperial College London Making some Power Moves as they Commence Internally Developed COVID-19 Vaccine & Launch ‘Social Enterprise’
9 months ago
Share

FDA Clears Moderna’s mRNA-1273 for Phase II Vaccine Clinical Trial to Target 600 Participants

The U.S. Food and Drug Administration has completed its review of Moderna’s Investigational New Drug (IND) application for its SARS-CoV-2 […]

FDA Clears Moderna’s mRNA-1273 for Phase II Vaccine Clinical Trial to Target 600 Participants
10 months ago
Share

Scripps Research Institute’s Matthew Disney Secures $11 Million from NIH for RNA-Targeted Medicine Including SARS-COV-2 Targets

The National Institute of Neurological Disorders and Stroke, (NINDS) part of the National Institutes of Health (NIH) in recognition of […]

Scripps Research Institute’s Matthew Disney Secures $11 Million from NIH for RNA-Targeted Medicine Including SARS-COV-2 Targets
10 months ago
Share

Moderna & Harvard Inc. Strategic Preclinical Research Pact Focusing on Immunological Diseases

Moderna Inc. is a clinical-stage biotech venture pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of […]

1 year ago
Share

UCSD-Derived  Gene Therapy Technology Secures $55 Million

Bradley J. Fikes of the San Diego Union Tribune reports  San Diego-based Locana has raised $55 million in venture capital […]

protein
2 years ago
Share

Expansion Therapeutics: The Race to “Drug RNA”

Founded in 2016, Expansion Therapeutics (Expansion) is a drug discovery and development company pursuing the vast potential of small molecule […]

2 years ago
Share

Origenis AI Discovery Platform Leveraged by Expansion Therapeutics

As reported by OA Online, Origenis has entered into a global license deal with Expansion Therapeutics. The two will collaborate on research […]

2 years ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.